The Federal Trade Commission took action to protect American patients from higher drug costs by requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc.
View Press Release
Marketing
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal
Source: US FTC Press — US Government, Public Domain